Present FutureFebruary 4 – March 3, 2023Opening: Saturday, February 4, 2023, 4:00 – 6:00 PMThe future is imminent. In the group exhibition at Artspace...
Eisai Co., Ltd. announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (HALAVEN, "eribulin") will be...
Eisai Co. Ltd announced today that the company will present research from its Alzheimer's disease (AD) pipeline, including new data for lecanemab (BAN2401), an...
LCSD to present Baroque Music Lecture Series "Bach & Beyond"
**********************************************************************
   The Leisure and Cultural Services Department (LCSD) will present the Baroque Music Lecture...
 Defense Strategies Institute is pleased to provide you with a highlight of SA Phillip Campbell, Division Chief, Innovation and Data Analytics Office, AFOSI, confirmed...
 NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, will participate in various...